Bridgewater Associates’s Mead Johnson Nutrition Company MJN Stock Holding History

Bridgewater Associates’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-154,120	Closed	-$10.9M	–	338
2016 Q4	$10.9M	Buy	154,120 +94,994	+161%	+$7.08M	0.1%	65
2016 Q3	$4.67M	Buy	59,126 +51,526	+678%	+$4.39M	0.05%	124
2016 Q2	$690K	Buy	7,600 +3,467	+84%	+$294K	0.01%	265
2016 Q1	$351K	Sell	4,133 -19,020	-82%	-$1.41M	﹤0.01%	248
2015 Q4	$1.83M	Sell	23,153 -95,615	-81%	-$7.53M	0.02%	191
2015 Q3	$8.36M	Buy	+118,768	New	+$9.77M	0.11%	87
2015 Q1	–	Sell	-20,018	Closed	-$2.01M	–	415
2014 Q4	$2.01M	Sell	20,018 -27,601	-58%	-$2.75M	0.02%	197
2014 Q3	$4.58M	Buy	+47,619	New	+$4.51M	0.04%	105
2014 Q1	–	Sell	-17,200	Closed	-$1.44M	–	404
2013 Q4	$1.44M	Buy	+17,200	New	+$1.4M	0.01%	187
2013 Q3	–	Sell	-5,700	Closed	-$452K	–	426
2013 Q2	$452K	Buy	+5,700	New	+$457K	﹤0.01%	261

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $20.5B AUM 26.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bridgewater Associates's MJN Position: Q1 2017 in Review

Bridgewater Associates sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 154,120 shares — an estimated $10.9M sold.

Bridgewater Associates first reported a position in MJN in Q2 2013 and held it in 10 quarters. The position peaked at $10.9M in Q4 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Bridgewater Associates reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Bridgewater Associates sold 154,120 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $10.9M.
Bridgewater Associates first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 10 quarters.
Bridgewater Associates's Mead Johnson Nutrition Company position peaked at $10.9M in Q4 2016.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Bridgewater Associates's 13F filing for Q1 2017, filed 11 May 2017.